CO2023007162A2 - Cápsulas de gelatina blanda de liberación retardada - Google Patents
Cápsulas de gelatina blanda de liberación retardadaInfo
- Publication number
- CO2023007162A2 CO2023007162A2 CONC2023/0007162A CO2023007162A CO2023007162A2 CO 2023007162 A2 CO2023007162 A2 CO 2023007162A2 CO 2023007162 A CO2023007162 A CO 2023007162A CO 2023007162 A2 CO2023007162 A2 CO 2023007162A2
- Authority
- CO
- Colombia
- Prior art keywords
- delayed release
- soft gelatin
- gelatin capsules
- release soft
- shell composition
- Prior art date
Links
- 230000003111 delayed effect Effects 0.000 title abstract 3
- 239000007903 gelatin capsule Substances 0.000 title abstract 2
- 230000001419 dependent effect Effects 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 108010010803 Gelatin Proteins 0.000 abstract 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 2
- 239000008121 dextrose Substances 0.000 abstract 2
- 229920000159 gelatin Polymers 0.000 abstract 2
- 239000008273 gelatin Substances 0.000 abstract 2
- 235000019322 gelatine Nutrition 0.000 abstract 2
- 235000011852 gelatine desserts Nutrition 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 2
- 235000010987 pectin Nutrition 0.000 abstract 2
- 229920001277 pectin Polymers 0.000 abstract 2
- 239000001814 pectin Substances 0.000 abstract 2
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 230000002028 premature Effects 0.000 abstract 1
- 229920001059 synthetic polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4833—Encapsulating processes; Filling of capsules
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Marine Sciences & Fisheries (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- General Preparation And Processing Of Foods (AREA)
Abstract
Cápsulas de gelatina blanda de liberación retardada que incluyen un material de relleno y una composición de la cubierta dependiente del pH. En una modalidad, la composición de la cubierta dependiente del pH incluye gelatina, pectina, dextrosa y de alrededor de 0,5% en peso a alrededor de 10 % en peso de un polímero sintético. En una modalidad alternativa, la composición de la cubierta dependiente del pH incluye gelatina, pectina, dextrosa y un ácido orgánico. La naturaleza de liberación retardada de las cápsulas inhibe la liberación prematura del material de relleno en pH ácidos (tales como pH entre alrededor de 1,2 y alrededor de 6).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063112453P | 2020-11-11 | 2020-11-11 | |
| PCT/US2021/072326 WO2022104339A1 (en) | 2020-11-11 | 2021-11-10 | Delayed release softgel capsules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO2023007162A2 true CO2023007162A2 (es) | 2023-06-20 |
Family
ID=81601948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CONC2023/0007162A CO2023007162A2 (es) | 2020-11-11 | 2023-05-30 | Cápsulas de gelatina blanda de liberación retardada |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230404926A1 (es) |
| EP (1) | EP4243772A1 (es) |
| JP (1) | JP2023548711A (es) |
| KR (1) | KR20230106642A (es) |
| CN (1) | CN116648238A (es) |
| AR (1) | AR124043A1 (es) |
| AU (1) | AU2021379780A1 (es) |
| CA (1) | CA3197522A1 (es) |
| CO (1) | CO2023007162A2 (es) |
| IL (1) | IL302753A (es) |
| MX (1) | MX2023005451A (es) |
| TW (1) | TW202233164A (es) |
| WO (1) | WO2022104339A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE1030928B1 (nl) * | 2022-09-29 | 2024-04-29 | Oystershell Nv | Zachte gummy |
| WO2024068991A1 (en) * | 2022-09-29 | 2024-04-04 | Oystershell Nv | Soft gummy |
| BE1030925B1 (nl) * | 2022-09-29 | 2024-04-29 | Oystershell Nv | Zachte gummy |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201304662D0 (en) * | 2013-03-14 | 2013-05-01 | Sigmoid Pharma Ltd | Compositions |
| WO2015200149A1 (en) * | 2014-06-23 | 2015-12-30 | Banner Life Sciences Llc | All natural enteric soft capsules comprising active ingredients |
| WO2018035356A1 (en) * | 2016-08-17 | 2018-02-22 | Eupraxia Pharmaceuticals Inc. | Sustained local delivery of drugs including antibiotics |
| US20220354800A1 (en) * | 2019-06-03 | 2022-11-10 | R.P. Scherer Technologies, Llc | Delayed release softgel capsules |
| MX2022005050A (es) * | 2019-10-28 | 2022-07-04 | Scherer Technologies Llc R P | Cápsulas de gelatina blanda de liberación retardada en entorno de ph más alto. |
-
2021
- 2021-11-10 EP EP21893068.3A patent/EP4243772A1/en active Pending
- 2021-11-10 MX MX2023005451A patent/MX2023005451A/es unknown
- 2021-11-10 CN CN202180089202.6A patent/CN116648238A/zh active Pending
- 2021-11-10 WO PCT/US2021/072326 patent/WO2022104339A1/en active Application Filing
- 2021-11-10 KR KR1020237018747A patent/KR20230106642A/ko unknown
- 2021-11-10 US US18/036,209 patent/US20230404926A1/en active Pending
- 2021-11-10 AU AU2021379780A patent/AU2021379780A1/en active Pending
- 2021-11-10 IL IL302753A patent/IL302753A/en unknown
- 2021-11-10 JP JP2023527995A patent/JP2023548711A/ja active Pending
- 2021-11-10 CA CA3197522A patent/CA3197522A1/en active Pending
- 2021-11-11 AR ARP210103125A patent/AR124043A1/es unknown
- 2021-11-11 TW TW110142057A patent/TW202233164A/zh unknown
-
2023
- 2023-05-30 CO CONC2023/0007162A patent/CO2023007162A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20230106642A (ko) | 2023-07-13 |
| AU2021379780A1 (en) | 2023-07-06 |
| IL302753A (en) | 2023-07-01 |
| JP2023548711A (ja) | 2023-11-20 |
| AR124043A1 (es) | 2023-02-08 |
| CA3197522A1 (en) | 2022-05-19 |
| WO2022104339A1 (en) | 2022-05-19 |
| MX2023005451A (es) | 2023-05-23 |
| US20230404926A1 (en) | 2023-12-21 |
| CN116648238A (zh) | 2023-08-25 |
| TW202233164A (zh) | 2022-09-01 |
| EP4243772A1 (en) | 2023-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2023007162A2 (es) | Cápsulas de gelatina blanda de liberación retardada | |
| AR111204A1 (es) | Composiciones agrícolas para una productividad mejorada de cultivos y fenotipos mejorados | |
| PE20170188A1 (es) | Formulaciones y metodos de tratamiento con queratina | |
| NI201100145A (es) | Composición farmacéutica sólida que comprende amlodipina y losartan con estabilidad mejorada. | |
| BR112021020485A2 (pt) | Produto destinado ao consumidor com liberação controlada, composições de microcápsula de núcleo-invólucro biodegradável | |
| CO2023007156A2 (es) | Cápsulas de gel blando de liberación retardada | |
| AR119075A1 (es) | Cápsulas blandas de liberación diferida | |
| AR089441A1 (es) | Capsulas de gelatina/alginato de liberacion retardada que comprenden acidos grasos omega-3 y metodos y usos de las mismas, metodo de manufactura, composicion farmaceutica | |
| CL2008001180A1 (es) | Un polvo bebestible instantaneo que comprende un agente de relleno y/o azucar recubiertas al menos parcialmente con un 0,1-5% de aceite de cadenas cortas de acidos grasos saturados de trigleceridos saturados c4-c14; capsula que comprende el polvo bebestible; metodo de produccion del polvo; kit que comprende un polvo bebestible. | |
| AR104458A1 (es) | Cartucho biodegradable para escopetas | |
| CO2022007168A2 (es) | Cápsulas de gelatina blanda de liberación retardada en ambientes de ph más alto | |
| PE20200223A1 (es) | Una composicion bioestimulante a base de taninos y/o sus derivados, para el tratamiento de plantas cultivadas y/o partes de las mismas | |
| CO2018004585A2 (es) | Colorantes naturales de genipina y una amina primaria, y procesos de elaboración de los mismos | |
| CL2018002688A1 (es) | Beta-caseinas y función cognitiva | |
| AR115269A1 (es) | Cápsulas de gelatina blanda entéricas | |
| AR086366A1 (es) | Producto lacteo congelable | |
| AR090888A1 (es) | Vehiculos de liberacion de composiciones pesticidas | |
| CL2017002967A1 (es) | Beta-caseinas a2 y capacidad antioxidante. | |
| ECSP19053583A (es) | Copolímero, solución acuosa que comprende el copolímero y procedimiento para reducir los efectos negativos del pitch natural y los contaminantes adhesivos, tanto en la fabricación de pasta como en la de papel | |
| AR117223A1 (es) | Aparato y proceso para el encapsulado secundario de inclusiones sólidas utilizando el proceso de matriz rotativa | |
| CL2022001066A1 (es) | Electrodo para el desprendimiento electroquímico de hidrógeno | |
| AR087032A1 (es) | Composiciones de capsulas de gelatina y metodos para fabricarlas | |
| AR090486A1 (es) | Golosina de tres capas con estabilidad temporal mejorada | |
| AR108732A1 (es) | Producción de anhídrido de sulfonilazida | |
| CO2021012391A2 (es) | Estabilidad api mejorada en capsulas blandas |